Search
Oregon State Pharmacy Association submits testimony to Oregon’s PDAB On May 6, the Oregon State Pharmacy Association (OSPA) submitted testimony for the Oregon Prescription Drug Affordability Board’s May 2025 meeting, suggesting that the board eliminate PBM spread pricing to improve prescription drug affordability. Read it here. Read the PDF. Learn more about: Upper payment limits PBM reimbursement practices Visit PSM’s…
Read More
Prescription Drug Affordability Board Activity, April 17 – April 30, 2025 Activities Summary Colorado: Colorado’s PDAB updated the Colorado Prescription Drug Affordability Advisory Council on its progress on April 24, 2025. Conversation focused on gathering stakeholder feedback. Maryland: Maryland’s Prescription Drug Affordability Advisory Council met on April 28,2025 to hear an expert presentation about Drug Pricing and the Supply Chain…
Read More
New research shows a correlation between compounded weight loss and diabetes injectables and increased adverse events. GIlead Sciences is suing another New York City pharmacy that allegedly sold counterfeit HIV medicine.
Read MoreThe FDA has issued a warning to the operators of the online pharmacy www.thesafepills.org for illegally selling unapproved and misbranded opioid medications, including tapentadol products marketed as Aspadol and Typendol. These unauthorized drugs, sold without a prescription, pose significant health risks such as overdose, addiction, and even death.
Read More
Industrial solvents in medicated syrups: A recurring nightmare In 2022, at least 300 children in Uzbekistan, Gambia and Indonesia died after their parents gave them cough syrup made by Indian and Indonesian manufacturers to relieve minor cold symptoms. Most of them were under the age of five. Packaging of cough syrups listed in WHO medical product alert 6/2022 What happened?…
Read More
One of SafeChain’s three owners pleaded guilty. The company collected secondhand HIV medicines from patients and resold them to licensed U.S. pharmacies, forging paperwork to make them look legitimate.
Read More
PSM submits written testimony on Michigan Senate Bills 3, 4, and 5 On April 23, The Partnership for Safe Medicines submitted written testimony in opposition to Michigan Senate Bills 3, 4, and 5, which would create a prescription drug affordability board (PDAB) in Michigan to establish upper payment limits on certain medicines. Read the testimony to learn why Michigan’s proposed…
Read More
Prescription Drug Affordability Board Activity through April 16, 2025 Activities Summary Colorado: Colorado’s PDAB met on April 11, 2025, where it addressed an error in All-Payer Claims Database data and how it affected affordability review information for Enbrel, Cosentyx and Stelara. Maryland: Maryland’s PDAB did not meet in April. Oregon: Oregon’s PDAB met on April 16, 2025 to review a…
Read More